Stage 1 hypertension
Pro Research Analysisby 
Searched over 200M research papers
Stage 1 Hypertension: Implications and Risks
Introduction to Stage 1 Hypertension
Stage 1 hypertension, as defined by the 2017 American College of Cardiology (ACC) and American Heart Association (AHA) guidelines, is characterized by systolic blood pressure (SBP) between 130-139 mmHg or diastolic blood pressure (DBP) between 80-89 mmHg. This redefinition has significant implications for cardiovascular health and disease prevention.
Cardiovascular Disease (CVD) Risk
Increased Risk of Cardiovascular Events
Research consistently shows that stage 1 hypertension is associated with an increased risk of cardiovascular disease (CVD) events. A meta-analysis of 16 studies involving over 3 million participants found that individuals with stage 1 hypertension had a 38% higher risk of CVD events compared to those with normal blood pressure . This increased risk extends to specific conditions such as coronary heart disease (CHD), stroke, and CVD mortality 135.
Age-Specific Differences
The impact of stage 1 hypertension on cardiovascular risk varies with age. In a study of Chinese adults, those aged 35-59 with stage 1 hypertension had significantly higher risks of CVD incidence and mortality compared to those with normal blood pressure. However, this association was not observed in individuals aged 60 and above . Similarly, rural women in China aged 45 and older with stage 1 hypertension showed increased risks of CVD mortality and stroke, while younger women did not exhibit the same risk elevation .
Pregnancy and Neonatal Outcomes
Adverse Pregnancy Outcomes
Stage 1 hypertension also poses risks during pregnancy. A systematic review and meta-analysis found that pregnant women with stage 1 hypertension had higher odds of adverse outcomes such as preterm delivery, low birth weight, and early-term delivery compared to those with normal blood pressure . Another study confirmed that stage 1 hypertension in pregnant women is associated with increased risks of hypertensive disorders of pregnancy, gestational diabetes, and preterm birth .
Long-Term Cardiovascular Risk
10-Year and Lifetime Risk
Long-term studies indicate that stage 1 hypertension significantly increases both 10-year and lifetime risks of cardiovascular disease. A prospective cohort study reported a 35% higher 10-year risk and a 36% higher lifetime risk of CVD for individuals with stage 1 hypertension compared to those with normal blood pressure . The risk is even more pronounced for those who progress to stage 2 hypertension, with a 156% increase in 10-year risk .
Progression and Maintenance of Hypertension
Maintaining stage 1 hypertension over time is associated with a higher risk of cardiovascular events. In a study of the Chinese Kailuan cohort, individuals who maintained stage 1 hypertension had significantly higher risks of cardiovascular events and cerebral infarction compared to those whose blood pressure returned to normal . Similarly, Korean adults who experienced an increase in blood pressure from normal to stage 1 hypertension had elevated risks of CVD and ischemic stroke .
Gender Differences in Risk
Acute Coronary Syndromes (ACS)
Gender differences in the impact of stage 1 hypertension have also been observed. In the Hordaland Health Study, stage 1 hypertension was a stronger risk factor for acute coronary syndromes (ACS) in women than in men. Women with stage 1 hypertension had more than double the risk of ACS compared to those with normal blood pressure, while the association was not significant in men .
Conclusion
Stage 1 hypertension, as defined by the 2017 ACC/AHA guidelines, is a significant risk factor for various adverse health outcomes, including cardiovascular events, adverse pregnancy outcomes, and long-term cardiovascular disease. The risks associated with stage 1 hypertension vary by age and gender, highlighting the need for targeted prevention and management strategies. Early detection and effective control of stage 1 hypertension could prevent a substantial proportion of cardiovascular events and improve overall health outcomes.
Sources and full results
Most relevant research papers on this topic